drugset / Trial / NCT00245856
Treatment of Upper Extremity Deep-Vein Thrombosis
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to document the long-term outcome or prognosis of patients diagnosed with upper extremity deep-vein thrombosis who are treated with Fragmin (dalteparin sodium injection) for three months.
Timeline
- Start
- 2002-09
- Primary completion
- 2009-03
- Completion
- 2011-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dalteparin sodium | Other / unclassified | 150 iu/kg | Subcutaneous |
| Subject | Dalteparin sodium | Other / unclassified | 200 iu/kg | Subcutaneous |
| Subject | Warfarin | Small molecule | — | — |